Aileron Therapeutics, Inc.

ALRN · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$4,048$5,722$7,428$12,865
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,126$880$903$792
Total Curr. Assets$5,174$6,602$8,331$13,657
Property Plant & Equip (Net)$0$1$1$1
Goodwill$6,330$6,330$6,330$6,330
Intangibles$42,200$42,200$42,200$42,200
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$2$2,346$766$2
Total NC Assets$48,532$50,877$49,297$48,533
Other Assets$0$0$0$0
Total Assets$53,706$57,479$57,628$62,190
Liabilities
Payables$4,123$6,028$1,149$911
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,621$1,666$4,828$4,838
Total Curr. Liab.$5,744$7,694$5,977$5,749
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$1,772$1,772$1,772$1,772
Other NC Liab.$0$0$0$277
Total NC Liab.$1,772$1,772$1,772$2,049
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$7,516$9,466$7,749$7,798
Equity
Pref Stock$45,005$45,005$45,005$45,005
Common Stock$111$131$108$108
Retained Earnings-$369,304-$363,723-$356,901-$351,400
AOCI-$44-$44-$32-$18
Other Equity$415,427$411,649$406,704$405,702
Total Equity$46,190$48,013$49,879$54,392
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$53,706$57,479$57,628$62,190
Net Debt-$4,048-$5,722-$7,428-$12,865